Embolic devices
US-2016367730-A1 · Dec 22, 2016 · US
US10194915B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10194915-B2 |
| Application number | US-201615272305-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 21, 2016 |
| Priority date | Dec 21, 2007 |
| Publication date | Feb 5, 2019 |
| Grant date | Feb 5, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described are devices for implantation comprising a hydrogel filament wherein the hydrogel filament includes a low molecular weight ethylenically unsaturated macromer, an ethylenically unsaturated monomer, and a visualization agent. Methods of making and using these devices are also described.
Opening claim text (preview).
We claim: 1. A device for implantation comprising: a hydrogel filament attached to a coupler wherein the coupler is attached to a pusher, wherein the hydrogel filament includes a low molecular weight ethylenically unsaturated macromer; an ethylenically unsaturated monomer; and visualization agent having a structure of 2,4,6-triiodophenyl penta-4-enoate, wherein said device contains no support members. 2. The device of claim 1 , wherein said macromer has a molecular weight of about 100 grams/mole to about 5000 grams/mole. 3. The device of claim 1 , wherein said macromer comprises polyethylene glycol, propylene glycol, poly(tetramethylene oxide), poly(ethylene glycol) diacrylamide, poly(ethylene glycol) diacrylate, poly(ethylene glycol) di methacrylate, derivatives thereof, or combinations thereof. 4. The device of claim 1 , wherein said macromer and said monomer are crosslinked with N,N,N′,N′-tetramethylethylenediamine, ammonium persulfate, azobisisobutyronitrile, benzoyl peroxides, 2,2′-azobis(2-methylpropionamidine) dihydrochloride, derivatives thereof, or combinations thereof. 5. The device of claim 1 , wherein said hydrogel is substantially free of acrylamide. 6. The device of claim 1 , wherein said hydrogel is substantially non-bioresorbable. 7. The device of claim 1 , wherein said visualization agent is at a concentration of about 40% w/w to about 80% w/w of a prepolymer solution used to form the hydrogel filament. 8. A device for implantation comprising: an introducer loaded with a hydrogel filament, wherein the introducer attaches to a catheter or microcatheter, wherein the hydrogel filament includes a low molecular weight ethylenically unsaturated macromer; an ethylenically unsaturated monomer; and visualization agent having a structure of 2,4,6-triiodophenyl penta-4-enoate, wherein said device contains no support members. 9. The device of claim 8 , wherein said macromer has a molecular weight of about 100 grams/mole to about 5000 grams/mole. 10. The device of claim 8 , wherein said macromer comprises polyethylene glycol, propylene glycol, poly(tetramethylene oxide), poly(ethylene glycol) diacrylamide, poly(ethylene glycol) diacrylate, poly(ethylene glycol) di methacrylate, derivatives thereof, or combinations thereof. 11. The device of claim 8 , wherein said macromer and said monomer are crosslinked with N,N,N′,N′-tetramethylethylenediamine, ammonium persulfate, azobisisobutyronitrile, benzoyl peroxides, 2,2′-azobis(2-methylpropionamidine) dihydrochloride, derivatives thereof, or combinations thereof. 12. The device of claim 8 , wherein said hydrogel is substantially free of acrylamide. 13. The device of claim 8 , wherein said hydrogel is substantially non-bioresorbable. 14. The device of claim 8 , wherein said visualization agent is at a concentration of about 40% w/w to about 80% w/w of a prepolymer solution used to form the hydrogel filament.
(bio)absorbable, (bio)resorbable or resorptive · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)} · CPC title
Porous materials, {e.g. foams or sponges} · CPC title
containing barium sulfate · CPC title
Use of materials characterised by their function or physical properties · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.